USPTO serial 79252260
ACCENTIS
Reviewed by CopyMark Law Group
Reg. 5923460Status 709
- Filing date
- Status date
- Registration date
- Dec 3, 2019
- Examiner
- EINSTEIN, MATTHEW T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ACCENTIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
EUROIMMUN Medizinische Labordiagnostika AG
DE
Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
EUROIMMUN Medizinische Labordiagnostika AG
DE
Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
EUROIMMUN Medizinische Labordiagnostika AG
DE
Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevan L. Morgan
Kevan L. Morgan Seed IP Law Group LLP701 Fifth Avenue, Suite 5400Seattle, WA 98104UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations, except for medical or veterinary purposes; diagnostic agents and diagnostic substances for scientific purposes, in particular immobilized proteins, nucleic acids, allergens, antibodies and tissue sections on a carrier, in particular a biochip, a microsphere, a paper ring, a test strip, a blot, a microtiter plate or a membrane | SECTION 71 - CANCELLED | — |
| 009 | UV fluorescence and chemiluminescence detectors for preparing, processing, and evaluating diagnostic samples for the detection of allergies, neurological diseases, infectious diseases, autoimmune diseases, and cancer; apparatuses for recording, transmission and reproduction of diagnostic data, sound or images, in particular cameras, microscopes, photometers, chemiluminescence detectors, in particular chemiluminescence immunoassay (CLIA)-readers, microplate photometers, enzyme linked immunosorbent assay readers, photomultipliers, and microplate readers; software, in particular laboratory software for recording, transmitting, and reproducing diagnostic data, sound, or images and software for operating and evaluating chemiluminescence detectors | SECTION 71 - CANCELLED | — |
| 010 | Chemiluminescence detectors for medical examinations and medical diagnosis, in particular chemiluminescence-immunoassay (CLIA)-readers for the detection of allergies, neurological diseases, infectious diseases, autoimmune diseases, and cancer | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
- Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
- Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named ACCENTIS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 19, 2026 | C71T | CANCELLED SECTION 71 | — |
| Dec 3, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 10, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 20, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 20, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 3, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 3, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 17, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 17, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 28, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 15, 2019 | ALIE | ASSIGNED TO LIE | — |
| Aug 8, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 1, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 31, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 31, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 29, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 13, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 12, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 1, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 1, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 28, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 25, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 21, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |